Medline Inc. (NASDAQ:MDLN) is one of the best NASDAQ stocks to buy according to hedge funds. On February 25, Medline reported its Q4 and full-year 2025 financial results, marking a significant year ...

Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Distribution Center of the Year and Safety, ...

Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., ...

Medline has signed a new supply agreement with Better Life Medical & Surgical Supply, a home medical equipment (HME) provider in Hallandale Beach, Fla.

Medline (Nasdaq:MDLN) today announced an underwritten public offering of 75 million shares of its Class A common stock.

The CEO of Northfield-based Medline cheered the company’s successful initial public offering late last year while discussing ...

Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief ...

Medline used its first earnings call since going public in December to assure investors that the company is well-positioned to support a health care industry facing what CEO Jim Boyle ...

Medline (Nasdaq:MDLN) posted fourth-quarter results that topped sales expectations but fell short of earnings forecasts.

Medical- and surgical-product company Medline priced a secondary offering of 75 million shares at $41.00 each.

Medline delivered strong sales despite net income decreases in the fourth quarter and 2025 in its first quarterly filing since becoming a publicly traded company last year.

Medline expands recall reprocessed catheters due to particulate risks that may cause infection or embolism, per FDA Class I alert.